If it's statistically significant, and safe it means it works well. And doctors should prescribe both.
- Forums
- ASX - By Stock
- OPT
- Ann: Opthea Meets Primary Endpoint in Phase 2b Study of OPT-302
Ann: Opthea Meets Primary Endpoint in Phase 2b Study of OPT-302, page-5
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
86.8¢ |
Change
-0.028(3.07%) |
Mkt cap ! $1.064B |
Open | High | Low | Value | Volume |
88.5¢ | 88.5¢ | 85.8¢ | $1.331M | 1.533M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 21705 | 86.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
87.0¢ | 20882 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 21070 | 0.865 |
12 | 59243 | 0.860 |
12 | 98865 | 0.855 |
9 | 71430 | 0.850 |
5 | 130879 | 0.845 |
Price($) | Vol. | No. |
---|---|---|
0.870 | 20882 | 12 |
0.875 | 55643 | 13 |
0.880 | 61071 | 12 |
0.885 | 22024 | 5 |
0.890 | 147340 | 6 |
Last trade - 11.29am 08/10/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |